Makoto Nakiri Selected Research

Makoto Nakiri Research Topics

11	Renal Cell Carcinoma (Grawitz Tumor) 05/2022 - 01/2013
8	Prostatic Neoplasms (Prostate Cancer) 07/2022 - 01/2008
6	Neoplasms (Cancer) 04/2022 - 03/2013
4	Neoplasm Metastasis (Metastasis) 09/2018 - 03/2013
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 07/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2022
1	Margins of Excision 04/2022
1	Dysuria 06/2021
1	Urination Disorders 06/2021
1	Hyperplasia 06/2021
1	Paraganglioma (Paragangliomas) 09/2020
1	Spontaneous Remission 07/2016
1	Multiple Pulmonary Nodules 07/2016
1	Fatigue 06/2016
1	Infarction (Infarctions) 06/2016
1	Disease Progression 06/2016
1	Polyps 01/2016
1	Hematoma 09/2015
1	Abdominal Pain (Pain, Abdominal) 09/2015
1	Hemorrhage 09/2015
1	Carcinoma (Carcinomatosis) 03/2013
1	Adenocarcinoma 03/2013
1	Polycythemia (Erythrocytosis) 01/2013

3	Biomarkers (Surrogate Marker)IBA 05/2022 - 11/2018
3	Iodine-125IBA 04/2022 - 07/2014
2	NivolumabIBA 05/2022 - 02/2022
2	Erythropoietin FDA Link 11/2019 - 01/2013
1	Hormones (Hormone)IBA 07/2022
1	IpilimumabIBA 05/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2019
1	EphA2 ReceptorIBA 11/2019
1	Immune Checkpoint InhibitorsIBA 11/2019
1	Proteins (Proteins, Gene)FDA Link 11/2019
1	EnzymesIBA 11/2019
1	Axitinib (AG 013736)IBA 09/2018
1	antineoplaston A10 (A 10)IBA 08/2017
1	Sorafenib (BAY 43-9006)FDA Link 06/2016
1	Hemoglobins (Hemoglobin)IBA 09/2015
1	Prostate-Specific Antigen (Semenogelase)IBA 07/2014
1	AndrogensIBA 03/2013
1	Sunitinib (Sutent)FDA Link 01/2013

7	Therapeutics 07/2022 - 01/2013
5	Brachytherapy 07/2022 - 07/2014
4	Prostatectomy (Retropubic Prostatectomy) 04/2022 - 01/2008
4	Molecular Targeted Therapy 02/2022 - 06/2015
2	Radiotherapy 07/2022 - 03/2013
2	Drug Therapy (Chemotherapy) 04/2022 - 03/2013
2	Cystectomy 04/2022 - 09/2020
2	Aftercare (After-Treatment) 06/2021 - 07/2014
2	Nephrectomy 09/2018 - 07/2016
1	Solid-State Lasers 07/2022
1	Transurethral Resection of Bladder 04/2022
1	Contraindications 06/2021
1	Ureteroscopes 01/2016
1	Intra-Arterial Infusions 03/2013